Advisors Asset Management Inc. Purchases 21,413 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Advisors Asset Management Inc. increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 28.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,430 shares of the company's stock after buying an additional 21,413 shares during the period. Advisors Asset Management Inc.'s holdings in GE HealthCare Technologies were worth $9,144,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. O Shaughnessy Asset Management LLC grew its holdings in GE HealthCare Technologies by 19.1% during the first quarter. O Shaughnessy Asset Management LLC now owns 16,090 shares of the company's stock valued at $1,463,000 after purchasing an additional 2,577 shares during the period. Lake Street Advisors Group LLC acquired a new position in GE HealthCare Technologies during the first quarter valued at approximately $211,000. Crewe Advisors LLC acquired a new position in GE HealthCare Technologies during the first quarter valued at approximately $98,000. EntryPoint Capital LLC boosted its holdings in shares of GE HealthCare Technologies by 680.0% in the first quarter. EntryPoint Capital LLC now owns 468 shares of the company's stock valued at $43,000 after buying an additional 408 shares during the period. Finally, CreativeOne Wealth LLC acquired a new position in shares of GE HealthCare Technologies in the first quarter valued at approximately $212,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

Shares of GEHC traded down $0.76 during mid-day trading on Thursday, reaching $84.14. The company had a trading volume of 1,268,092 shares, compared to its average volume of 3,049,602. The company's 50 day simple moving average is $88.54 and its 200 day simple moving average is $83.58. GE HealthCare Technologies Inc. has a 1-year low of $66.39 and a 1-year high of $94.55. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The company has a market capitalization of $38.44 billion, a price-to-earnings ratio of 23.32, a P/E/G ratio of 2.96 and a beta of 1.24.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.06 by $0.08. The business had revenue of $4.86 billion during the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm's quarterly revenue was up .9% on a year-over-year basis. During the same quarter last year, the business earned $0.99 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a $0.03 dividend. The ex-dividend date was Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.30%.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the firm's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.27% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages recently commented on GEHC. UBS Group cut shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and reduced their target price for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. Stifel Nicolaus increased their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a research report on Monday, September 30th. Redburn Atlantic raised shares of GE HealthCare Technologies to a "strong-buy" rating in a research report on Thursday, August 1st. Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a research report on Tuesday, October 1st. Finally, Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research report on Thursday, October 31st. One analyst has rated the stock with a sell rating, five have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of "Moderate Buy" and a consensus target price of $94.36.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.